{
  "id": "ACQ-13",
  "category": "Laboratory partnerships",
  "capability": "Share underused laboratory capabilities and undertake public-private work",
  "summary": "STRL partnership centers can permit private use of underused capabilities, perform cooperative work, leverage private recapitalization and credit receipts to cost-bearing funds.",
  "legal_basis": [
    {
      "citation": "10 U.S.C. §4124",
      "url": "https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title10-section4124&num=0&edition=prelim",
      "kind": "statute",
      "note": "Primary statutory text; primary GovInfo baseline and amendment audit identified in research narrative."
    }
  ],
  "authority_holder": "Secretary of Defense, authorized Center/STRL directors",
  "actor_chain": {
    "planner": [
      "Laboratory scientific lead and Office of Research and Technology Applications"
    ],
    "resource_owner": [
      "Laboratory director and sponsoring component budget owner"
    ],
    "approver": [
      "Laboratory director and agency approver as statute/delegation requires"
    ],
    "executor": [
      "Laboratory ORTA, counsel and authorized agreement official"
    ],
    "partners": [
      "Industry, universities, nonprofit and government collaborators within eligibility limits"
    ]
  },
  "actor_sources": [
    {
      "title": "Army Technology Transfer Program — agreement tools and laboratory roles",
      "url": "https://www.t2.army.mil/T2-Program/T2-Agreements/"
    },
    {
      "title": "Air Force Offices of Research and Technology Applications — coordination role",
      "url": "https://www.aft3.af.mil/Office-of-Research-and-Technology-Application-ORTA/"
    }
  ],
  "requirements": [
    "Use supports statutory partnership objectives and does not significantly impair laboratory mission.",
    "Private partner agrees to required direct/indirect cost reimbursement and indemnification."
  ],
  "limits": [
    "No authorization for otherwise-prohibited conversion of government work to contractors.",
    "War/emergency can suspend access; unused capability is not a blanket disposal of public assets."
  ],
  "funding": [
    "Reimbursement to appropriation, working-capital or revolving fund incurring costs; alternative statutory reinvestment conditions."
  ],
  "coordination_path": "Lab director/ORTA identifies spare capability → mission-impact and reimbursement determination → partner agreement → lab comptroller credits authorized receipts.",
  "availability": "Express statutory pathway; award-specific appropriations, available balances, delegations, implementation and approvals not independently verified.",
  "confidence": "High on express authority and cited conditions; execution assignment is illustrative unless statute expressly names it.",
  "currentness": "GovInfo 2024 Code (includes FY2025 NDAA, P.L. 118-159) read in full for cited provision; targeted FY2026 NDAA P.L. 119-60 amendment/repeal sweep. No claim of complete legislative currency through 2026-10-02; remaining 2026 delta needs counsel validation.",
  "family": "Research, innovation and experimentation",
  "mechanisms": [
    "Other statutory tools"
  ],
  "goal_ids": [
    "develop-technology"
  ],
  "office_links": []
}